Candel Therapeutics Inc
Biotechnology
Healthcare
CADL
31.68 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
5.30
52 week high
12.21
high
5.49
52 week low
0.00
low
5.23
growth
-29.84 %
previous Close
5.23
P/E ratio
market cap
318 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top